The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
Authors:
Open Access
- 21 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 2160
Abstract
Immune checkpoint therapy (ICT) has shown promising potential in the treatment of multiple solid tumors. However, the role of ICT in pancreatic ductal adenocarcinoma (PDAC) remains limited. Patterns of immune checkpoints (ICs) in PDAC represent the basis for establishing a potent ICT. The aim of this study is to create a profile of IC expression and its prognostic relevance in cancer cells of PDAC. Therefore, tumor cells from peripheral and central tissue microarray (TMA) spots from histologically confirmed PDAC of 68 patients after tumor resection were investigated in terms of expressions of TIM3, IDO, B7H4, LAG3, VISTA, and PD-L1 using immunohistochemistry. The presence of the respective ICs was compared to overall survival (OS). The presence of VISTA and PD-L1 significantly correlates with shorter OS (median OS: 22 months vs. 7 months and 22 months vs. 11 months, respectively, p < 0.05). For the presence of TIM3, IDO, B7H4, and LAG3, no difference in OS was observed (p > 0.05). The analysis of OS of combined subgroups for VISTA and PD-L1 (VISTA and PD-L1 neg., VISTA pos. and PD-L1 neg., VISTA neg. and PD-L1 pos., and VISTA and PD-L1 pos.) yielded overall statistical significance difference (p = 0.02). These results suggest that the presence of VISTA and PD-L1 is of prognostic relevance and potentially qualifies them as targets for ICT.Keywords
Funding Information
- Berliner Krebsgesellschaft (DRFF202204)
This publication has 27 references indexed in Scilit:
- Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatmentBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk FactorsWorld Journal of Oncology, 2019
- VISTA expressed in tumour cells regulates T cell functionBritish Journal of Cancer, 2018
- PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assayDiagnostic Pathology, 2018
- Integrated Genomic Characterization of Pancreatic Ductal AdenocarcinomaCancer Cell, 2017
- Immune Escape Mechanisms as a Guide for Cancer ImmunotherapyClinical Cancer Research, 2015
- Tim-3 Expression in Cervical Cancer Promotes Tumor MetastasisPLOS ONE, 2013
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- B7-H3 and B7-H4 expression in non-small-cell lung cancerLung Cancer, 2006
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaJournal of Experimental Medicine, 2006